KP
Kaveri Pohlman Clear Street Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
100%
Neutral
0%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $12 |
494%
upside
| 1 | -19% |
0
%
| 30 Dec ‘25 8 days ago |
|
|
|
Buy
Maintained
| $99 |
49%
upside
| 1 | -5.3% |
0
%
| 9 Dec ‘25 29 days ago |
|
|
|
Buy
Initiated
| $200 |
98%
upside
| 1 | +7.7% |
0
%
| 5 Dec ‘25 1 month ago |
|
|
|
Buy
Maintained
| $32 |
129%
upside
| 1 | -59% |
0
%
| 2 Dec ‘25 1 month ago |
|
|
|
Buy
Initiated
| $25 |
90%
upside
| 1 | +8.6% |
0
%
| 25 Nov ‘25 1 month ago |
|
|
|
Buy
Maintained
| $21 |
79%
upside
| 1 | +2.2% |
0
%
| 14 Nov ‘25 1 month ago |
|
|
|
Buy
Initiated
| $18 |
241%
upside
| 1 | +14% |
0
%
| 13 Nov ‘25 1 month ago |
|
|
|
Buy
Initiated
| $29 |
425%
upside
| 1 | -29% |
0
%
| 22 Oct ‘25 2 months ago |
|
|
|
Buy
Maintained
| $60 |
85%
upside
| 2 | +11% |
0
%
| 21 Oct ‘25 2 months ago |
|
|
|
Buy
Initiated
| $11 |
20%
downside
| 1 | +341% |
0
%
| 1 Oct ‘25 3 months ago |
|
|
|
Buy
Maintained
| $46 | – | 1 | +80% |
0
%
| 17 Sep ‘25 3 months ago |
|
|
|
Buy
Initiated
| $32 |
63%
upside
| 1 | -15% |
0
%
| 25 Jun ‘25 6 months ago |
|